av Aina Rengmark | nov 15, 2023
BUSINESS OPPORTUNITY Leading scientists at the Oslo University Hospital have identified a unique biomarker in patients with basal-like breast cancer, which indicates a favorable prognosis. This group of patients largely represents those with triple-negative breast...
av Lise Rødsten | okt 20, 2021
BUSINESS OPPORTUNITY Scientists at Oslo University Hospital are developing a urine based test, addressing a major unmet need for non-invasive detection and monitoring of bladder cancer. Bladder cancer carries the highest per- lifetime, per-patient cost of any type of...
